Kanglong Huacheng (stock code: 300759.SZ/3759.HK) is an international leading life science research and development service company. Since its establishment in 2004, Kanglong Huacheng has been committed to its talent training and facility construction, creating a running drug discovery, preclinical and clinical development for the research and development of multi-therapeutic drugs including small molecules, large molecules, and cell and gene therapy drugs. Develop a full-process R&D and production service system. Kanglong Huacheng operates in China, the United States and the United Kingdom, with more than 20,000 employees, providing R&D solutions to partners in North America, Europe, Japan and China and maintaining good cooperative relationships with them.